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Abstract
Background: In 2009, Chinese government launched a new healthcare reform, one of the key points of which
is to establish National Essential Medicine System (NEMS). Hospital pharmacists are directly related to the
implementation of NEMS. This study is to examine knowledge of and attitudes towards the implementation
of the NEMS among hospital pharmacists in western China.
Methods: We conducted a questionnaire survey of pharmacists from different types of medical institutions in
Shaanxi Province in November 2014. We gathered demographic information about the participants, collected the
data about their knowledge of and attitudes towards the implementation of NEMS, and identified the influencing
factors of cognitive level. We analyzed the data and compared public secondary/tertiary hospitals and primary
healthcare institutions.
Results: Of the 704 participants (response rate = 70.2 %), the majority had positive and moderate knowledge
(39.2 and 53.3 %) and attitudes (35.8 and 62.9 %) towards NEMS. The most participants were aware of the
implementation time of NEMS (89.8 %) and zero mark-up policy (85.5 %) while the least learned of the adjustment
time of National Essential Medicines List (NEML). Pharmacists from public secondary/tertiary hospitals tended to
know more and have more positive attitudes. There was no statistical correlation between knowledge and attitude
scores. The education level (p = 0.022) and number of training sessions attended (p = 0.028) were the only
demographic variables linked to knowledge scores.
Conclusions: Hospital pharmacists in Shaanxi Province had moderate knowledge of and attitudes towards the
implementation of NEMS. Pharmacists from public secondary/tertiary hospitals showed better understanding.
The government should therefore focus on improving the understanding of pharmacists in primary healthcare
institutions and also address existing problems, especially the supply and distribution systems.
Keywords: National Essential Medicines System (NEMS), Pharmacists, Knowledge, Attitudes, Primary healthcare
institution, Public secondary/tertiary hospital
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Background
The past three decades have seen rapid economic growth
in China, but no similar improvement in health services
[1–3]. There has been sustainable growth in total health
expenditure—5.36 % of gross domestic product (GDP) in
2012 [4]. Although the percentage of individual out-of-
pocket payments is declining [5], high out-of-pocket pay-
ments still place huge financial burdens on many people
[6]. To provide affordable, equitable access to high-quality
health services for all citizens by 2020, the Chinese govern-
ment launched a nationwide systematic reform in 2009 [7],
one of the key pillars of which is the establishment and im-
plementation of the National Essential Medicines System
(NEMS). In order to make NEMS benefit the general
population, this policy put great emphasis on medicines ac-
cessibility and affordability.
The NEMS is a comprehensive measure covering medi-
cine selection, production, pricing, procurement, prescrib-
ing and reimbursement [8]. One of the most remarkable
aspects of it is a zero mark-up policy for government-run
primary healthcare institutions. This means that medicines
included on the National Essential Medicines List (NEML)
are sold to patients at cost [9]. As a result, the NEML can-
not meet the specific service needs of primary health care
institutions [10], such as gynecological medicines and
pediatric drugs.
When all primary healthcare institutions had imple-
mented this policy in 2012 [11], the focus shifted to
county hospitals. The government has been promoting
and expanding the priority use of essential medicines, as
well as the proportion available in secondary and tertiary
hospitals [12].
There are many literatures concerning the NEMS and
a good deal of research has focused on indicators of ef-
fect, such as availability [13], affordability [14] and ra-
tional drug use [15, 16]. Some studies have also
evaluated the effects of NEMS on healthcare workers
[17–19], but there are still limits to the information
available. For example, most research has focused on
primary healthcare institutions, and there is little evi-
dence about secondary/tertiary hospitals [18, 20]. Most
studies also focus on doctors [17, 18]. Although their
knowledge and attitudes are important to the implemen-
tation of NEMS, other medical staff are also closely
involved.
By the end of 2014, there were 948,000 medical insti-
tutions in China, including 26,000 hospitals, 922,000
grassroots hospitals. All these medical institutions
should have pharmacy departments and certain number
of pharmaceutical professionals (pharmacists and phar-
macy technicians), which generally accounting for 8 % of
all professionals [21]. The main responsibility of hospital
pharmacy is assuring the medicine quality, guiding ra-
tional drug use and making medicines be placed in
proper storage conditions. The responsibility of hospital
pharmacists is involving many aspects, of which the
basic duty is ensuring the quality and supply of medi-
cines and carrying out “patient-centered” clinical work
[22]. Hospital pharmacists are in charge of monitoring
prescriptions, dispensing medication and providing guid-
ance on the use of medicines. They are therefore directly
concerned with selection, procurement, distribution, and
use of medicines [23], and play an important role in the
implementation of the NEMS. In primary healthcare in-
stitutions, operating the zero mark-up policy, pharma-
cists actively implement the NEMS. Implementing the
zero mark-up policy in public secondary and tertiary
hospitals will inevitably affect the way in which pharma-
cists work, as well as their pay, job satisfaction and the
drug supply and distribution system. After the launch of
this policy, most cities established compensation policies
to pay staff a basic salary plus a bonus based on per-
formance. The performance criteria include quality of
services and achieved social responsibilities such as con-
trolling cost escalation. It is therefore very important to
study the impact of NEMS on primary and higher-level
hospital pharmacists.
Internationally, there are corresponding studies on
pharmacists’ influences on prescribing [24], rational drug
use [25] and opinions on adverse drug reaction reporting
[26]. However, there are few studies on hospital pharma-
cists’ understanding about the NEMS. We therefore con-
ducted a questionnaire survey of pharmacists in tertiary,
secondary, and primary healthcare institutions in Shaanxi
Province, western China. This aimed to examine their
knowledge of and attitudes towards the implementation of
the NEMS, and explore their views on problems and how
these could be resolved.
Methods
Study design
A questionnaire was designed to probe pharmacists’
knowledge and perceptions of and attitudes towards the
implementation of the NEMS in public secondary/ter-
tiary hospitals and primary healthcare institutions. The
survey was approved by the Ethical Committee of the
Health Science Center, Xi’an Jiaotong University.
Study area
The survey was conducted in Shaanxi Province [27].
Located in the western part of China, with a population
of more than 37 million, it has a low to medium GDP.
Shaanxi Province had a total of 181 primary healthcare
institutions, 278 secondary and 48 tertiary hospitals in
2012 [4]. Shaanxi’s government implemented the NEMS
in the form of a “triple unification” policy (unified bid-
ding, unified distribution, and unified pricing) [28]. Be-
cause all primary healthcare institutions have adopted
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the zero mark-up policy, the Shaanxi government is now
extending NEMS to secondary and tertiary hospitals.
Sampling
The survey was undertaken in November 2014. The ques-
tionnaire was distributed at the Western Area Pharmacists
Training Program, which was aiming at promoting hospital
pharmacists’ professional services and rational drug use,
run by the Shaanxi Health and Family Planning Commis-
sion, and attended by hospital pharmacists from across the
province. Every medical institution was required to send
two senior pharmacists to the training. The selected phar-
macists should be familiar with the operation and manage-
ment of hospital pharmacy and have at least a basic
understanding of the NEMS. The organizer would afford
all the charges except for the participants’ transport costs.
All participants had no prior information about the survey.
As a matter of convenience, we distributed the question-
naires to all attendees but only singled out public hospital
pharmacists as sample. Informed consent was obtained
from the training organizer. Before distributing the ques-
tionnaires, the conference host gave a brief introduction to
the research team and the purpose of this survey, so that
we could obtain participants’ oral agreement. Those who
completed the questionnaire were considered to have
consented.
Instruments
A covering letter was attached to introduce the purpose
and significance of this study. It explained that the sur-
vey was anonymous and for research purposes only, to
reassure the participants of anonymity and confidential-
ity. The questionnaires were self-administered during
break time at the conference and returned before
leaving.
The questionnaire was developed specifically for hos-
pital pharmacists and consisted of four parts. The first
part asked for participants’ demographic information.
The second assessed their knowledge of NEMS by six
questions about the implementation time, the NEML,
centralized procurement and distribution, zero mark-up
policy and medical insurance reimbursement. The third
part used five-point Likert scales to measure the phar-
macists’ attitudes towards the implementation of NEMS.
There are some barriers during the implementation of
NEMS, such as the medicines in NEML are not fully
meet the clinical utilization, the financial compensation
of local governments is not in place or the availability of
essential medicines is inadequate sometimes [28]. There-
fore the final part consisted of multiple choice questions
to evaluate views on the existing problems with the im-
plementation of NEMS, and suggestions for resolving
them. It included an option of “other” for new problems
and solutions.
The questionnaire was pre-tested on five pharmacists at
a tertiary hospital, and then adjusted slightly to ensure
that it was both appropriate and easy to understand. Its
validity and reliability were tested. Cronbach’s Alpha was
used to validate its internal consistency and the coefficient
of knowledge and attitude part were 0.81 and 0.76 respect-
ively, giving a reasonable level of validity for 0.7 is consid-
ered as the minimum reliable level of consistency [29, 30].
Four undergraduates from the medical college were re-
cruited and trained to carry out questionnaire distribution
and data collection. The investigators had no knowledge
of the research hypotheses and the correct answers to the
survey questions, to avoid any potential bias in the process
of data collection.
Data entry and analysis
Completed questionnaires were encoded and the data
were double-checked and verified for completeness
and consistency. The data were entered into Microsoft
Excel 2007 and analyzed using SPSS (version 18.0). All
data were checked by two of the authors before ana-
lysis. The second and third parts were transformed
into scores in Excel 2007. The knowledge part con-
tained a mixture of right and wrong statements, with
the answers classified into one of three options (yes,
no and don’t know). Each correct answer was scored
as 1 and a wrong or “don’t know” answer was scored
as 0. The total score for all knowledge questions was
calculated for each participant. For the attitude part,
the points on the response scale were: 1 = “strongly
disagree”, 2 = “disagree”, 3 = “neither agree nor dis-
agree”, 4 = “agree”, and 5 = “strongly agree”. The aver-
age value was calculated for total attitude score and
each statement score.
Total knowledge and attitudes scores were calculated
for every participant. The possible ranges were 6 (6–0 =
6) and 24 (30–6 = 24), and these were divided into three
equal parts. In order to quantify analysis, we took 60
and 80 % [31] as boundary point and also considered the
balance of the score spacing. The knowledge scores were
categorized as “negative” (0–2), “moderate” (3–4) and
“positive” (5–6), and the attitude scores were “negative”
(6–13), “moderate” (14–21) and “positive” (22–30).
The demographic information was included as pub-
lic secondary/tertiary hospitals, primary healthcare in-
stitutions and overall. The knowledge and attitudes of
pharmacists from public secondary/tertiary hospitals
and primary healthcare institutions were compared
using a chi-square test. Multiple linear regression was
used to identify the determinants of knowledge scores.
Bivariate correlation analysis was used to analyze the
relationship between knowledge and attitude scores. A
type 1 error of 0.05 was used as the threshold of statis-
tical significance.
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Results
Demographics
Of the 1003 questionnaires distributed, 228 from private
hospital pharmacists were eliminated and 71 were un-
usable because of missing data, so only 704 were eligible
(response rate = 70.2 %). Participants’ demographic in-
formation is summarized in Table 1. A total of 525
(74.6 %) participants were from public secondary/tertiary
hospitals and 179 (25.4 %) from primary healthcare insti-
tutions; 445 (63.2 %) were female and 259 (36.8 %) were
male. Similar numbers of participants had a bachelor’s
degree (42.0 %, 296/704) or a college diploma (40.1 %,
282/704). Only 29 (4.1 %) had a master’s degree or
above. Half of the participants (50.9 %, 358/704) had a
title of intermediate technician. The amount of training
received varied: none (33.2 %, 234/704), 1–2 courses
(55.4 %, 390/704), 3–5 courses (9.9 %, 70/704) and more
than 5 courses (1.4 %, 10/704). Education level (p <
0.001) and technician title (p < 0.001) were the only
demographic variables that were significantly different in
public secondary/tertiary hospitals and primary health-
care institutions (Table 1).
Knowledge of hospital pharmacists about NEMS
The mean value for the total knowledge score was 4.09
± 1.11. This was classified as “moderate”. Positive know-
ledge was achieved by 39.2 % of the participants, with
53.3 % achieving moderate knowledge, and 7.5 % nega-
tive. Coincidentally, 7.5 % of participants also obtained
the maximum scores. The majority of participants were
Table 1 Demographic characteristics of hospital pharmacists in Shaanxi Province
Demographic information Public secondary/tertiary hospitals n (%) Primary healthcare institutions n (%) Overall n (%) p-value
Sex 0.324
Male 199 (37.9) 60 (33.5) 259 (36.8)
Female 326 (62.1) 119 (66.5) 445 (63.2)
Age group (years) 0.516
≤ 25 36 (6.9) 10 (5.6) 46 (6.5)
26–35 161 (30.7) 61 (34.1) 222 (31.5)
36–45 186 (35.4) 67 (37.4) 253 (35.9)
46–55 125 (23.8) 33 (18.4) 158 (22.4)
≥ 56 17 (3.2) 8 (4.5) 25 (3.6)
Working years group 0.272
≤ 5 101 (19.2) 28 (15.6) 129 (18.3)
6–10 70 (13.3) 35 (19.6) 105 (14.9)
11–20 147 (28.0) 53 (29.6) 200 (28.4)
21–30 164 (31.2) 50 (27.9) 214 (30.4)
≥ 31 43 (8.2) 13 (7.3) 56 (8.0)
Education level <0.001
Master and above 28 (5.3) 1 (0.6) 29 (4.1)
Bachelor 251 (47.8) 45 (25.1) 296 (42.0)
College 182 (34.7) 100 (55.9) 282 (40.1)
Secondary school or below 64 (12.2) 33 (18.4) 97 (13.8)
Technical title <0.001
Senior 96 (18.3) 9 (5.0) 105 (14.9)
Intermediate 275 (52.4) 83 (46.4) 358 (50.9)
Junior 144 (27.4) 75 (41.9) 219 (31.1)
None 10 (1.9) 12 (6.7) 22 (3.1)
Number of training sessions received 0.068
None 160 (30.5) 74 (41.3) 234 (33.2)
1–2 courses 303 (57.7) 87 (48.6) 390 (55.4)
3–5 courses 54 (10.3) 16 (8.9) 70 (9.9)
More than 5 courses 8 (1.5) 2 (1.1) 10 (1.4)
All p-values are based on chi-square analysis
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aware of the official implementation time of NEMS
(86.8 %, 611/704), zero mark-up policy (85.5 %, 602/
704), supply pattern (77.7 %, 547/704) and medical in-
surance reimbursement (76.8 %, 541/704). Fewest partic-
ipants (21.4 %, 151/704) knew about the adjustment
time of the NEML. Hence, their knowledge level was ac-
ceptable except about the adjustment time of the NEML.
There was a significant difference (p = 0.003) in know-
ledge about the zero mark-up policy between public
secondary/tertiary hospitals and primary healthcare in-
stitutions (Table 2).
Sources of information about NEMS
The majority of the research participants reported that
they had learned about NEMS through conferences
(71.0 %, 500/704) followed by the Internet (42.3 %, 298/
704) and journals (30.3 %, 213/704). Only 189 (26.8 %)
participants obtained information from traditional media
and 57 (8.1 %) obtained information from other sources,
such as brochures, government documents and profes-
sional books.
Attitudes towards the implementation of NEMS
The average value of total attitudinal score was 20.36 ± 2.96
and the range was from 11 to 30. The categories were
35.8 % positive, 62.9 % moderate and 1.3 % negative. Ap-
proximately two thirds of the sample approved (strongly
agree: 8.4 %, 59/704 and agree: 55.1 %, 388/704) of improv-
ing rational drug use while less than half (strongly agree:
4.4 %, 31/704 and agree: 31.5 %, 222/704) thought that the
effect of implementation of NEMS at present was satisfac-
tory. Participants were least likely to agree that NEMS
would affect staff income (strongly agree: 6.0 %, 42/704 and
agree: 30.4 %, 214/704). Attitudes were not significantly
different between public secondary/tertiary hospitals and
primary healthcare institutions (Table 3). Bivariate correl-
ation analysis showed there was no correlation between
knowledge and attitude scores (p > 0.05).
Effect of demographic factors on knowledge about NEMS
Table 4 shows the association between knowledge scores
and demographic variables among the study population
in the multiple linear regression analysis. Knowledge
about NEMS was significantly associated with education
level (p = 0.022) and the number of training sessions re-
ceived (p = 0.028). In the complete model (Model 2),
study participants’ knowledge scores were positively re-
lated to education level (β 0.131; 95 % confidence inter-
val [CI] 0.019–0.242) and the number of training
sessions received (β 0.145; 95 % CI 0.016–0.274).
Problems with the implementation of NEMS, and
solutions to address them
A total of 591 (83.9 %) participants regarded the supply
and distribution system as a big problem, followed by in-
sufficient government funding (65.5 %, 461/704) and in-
sufficient number of essential medicine types (60.8 %,
428/704). Only 174 (24.7 %) of participants agreed that
the way in which the NEML was determined was a
problem.
In relating to suggestions for improving the implemen-
tation of NEMS, most participants approved of rational
selection and use (84.7 %, 596/704) and reliable systems
(87.9 %, 619/704). More than half favored sustainable
funding (67.2 %, 473/704) and affordable prices (58.4 %,
411/704).
Discussion
Five years after the launch of the healthcare reforms and
implementation of the NEMS, some achievements have
been made [32, 33]. This study has shown that hospital
pharmacists have moderate knowledge of and attitudes to-
wards NEMS. This finding is similar to the studies [18, 19]
targeting on doctors and the medical staff in primary hos-
pital. And basically all the respondents learn of the NEMS
in their studies. Xu Y et al. [20] found that medical staff
had much knowledge of types and therapeutic efficacy of
essential medicines. In our study, the hospital pharmacists
Table 2 Knowledge level of hospital pharmacists about the NEMS
Items Correct answers n (%) p-value
Public secondary/tertiary hospitals Primary healthcare institutions Overall
Q10. The official implementation time of NEMS is 2009. 455 (86.7) 156 (87.2) 611 (86.8) 0.869
Q11. National Essential Medicines List (NEML) is
adjusted every 2 years in principle.
113 (21.5) 38 (21.2) 151 (21.4) 0.934
Q12. There are a total of 307 drugs in the latest
version of “National Essential Medicines List”.
319 (60.8) 107 (59.8) 426 (60.5) 0.816
Q13. Essential medicines are for provincial centralized
procurement and unified distribution
415 (79.0) 132 (73.7) 547 (77.7) 0.141
Q14. Zero mark-up policy is implemented in the NEMS. 461 (87.8) 141 (78.8) 602 (85.5) 0.003
Q15. Medicare insurance reimbursement of essential
medicines is the same as non-essential medicines.
404 (77.0) 137 (76.5) 541 (76.8) 0.909
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had a good knowledge of implementation time, zero mark-
up policy, supply pattern and reimbursement. However, the
majority have no idea of the adjustment time of the NEML.
The relevant questionnaire item was an incorrect statement
that the NEML is adjusted every 2 years. This may be a re-
sult of confusion about action in China and from the
World Health Organization (WHO). WHO sets a new es-
sential medicine list at least every 2 years [34], while China
operates a system of dynamic management, stipulating that
NEML should be adjusted every 3 years in principle [35].
Although zero mark-up policy had in theory been applied
in all primary healthcare institutions, there were still some
primary pharmacists who did not know about this policy.
This suggests that the NEMS had not been promoted ef-
fectively. Attitudes towards the implementation of NEMS
were generally classified as “moderate”. Surprisingly, only
Table 3 Attitudes towards the implementation of NEMS




Overall n (%) Mean ± SD p-value
Q17. The effect of implementation of NEMS is satisfactory at present. 3.28 ± 0.76 0.419
Strongly agree 22 (4.2) 9 (5.0) 31 (4.4)
Agree 156 (29.7) 66 (36.9) 222 (31.5)
Neither agree nor disagree 294 (56.0) 86 (48.0) 380 (54.0)
Disagree 41 (7.8) 14 (7.8) 55 (7.8)
Strongly disagree 12 (2.3) 4 (2.2) 16 (2.3)
Q18. The implementation of NEMS could guarantee the basic medical needs of the population. 3.50 ± 0.80 0.812
Strongly agree 36 (6.9) 16 (8.9) 52 (7.4)
Agree 243 (46.3) 86 (48.0) 329 (46.7)
Neither agree nor disagree 189 (36.0) 61 (34.1) 250 (35.5)
Disagree 52 (9.9) 15 (8.4) 67 (9.5)
Strongly disagree 5 (1.0) 1 (0.6) 6 (0.9)
Q19. The implementation of NEMS could reduce the healthcare burden of the population. 3.61 ± 0.85 0.425
Strongly agree 55 (10.5) 23 (12.8) 78 (11.1)
Agree 273 (52.0) 88 (49.2) 361 (51.3)
Neither agree nor disagree 135 (25.7) 50 (27.9) 185 (26.3)
Disagree 59 (11.2) 15 (8.4) 74 (10.5)
Strongly disagree 3 (0.6) 3 (1.7) 6 (0.9)
Q20. The implementation of NEMS could improve rational drug use. 3.63 ± 0.76 0.106
Strongly agree 39 (7.4) 20 (11.2) 59 (8.4)
Agree 284 (54.1) 104 (58.1) 388 (55.1)
Neither agree nor disagree 164 (31.2) 39 (21.8) 203 (28.8)
Disagree 35 (6.7) 14 (7.8) 49 (7.0)
Strongly disagree 3 (0.6) 2 (1.1) 5 (0.7)
Q21. The implementation of NEMS could change the working mode of hospital pharmacy. 3.27 ± 0.86 0.065
Strongly agree 21 (4.0) 9 (5.0) 30 (4.3)
Agree 195 (37.1) 85 (47.5) 280 (39.8)
Neither agree nor disagree 191 (36.4) 59 (33.0) 250 (35.5)
Disagree 111 (21.1) 25 (14.0) 136 (19.3)
Strongly disagree 7 (1.3) 1 (0.6) 8 (1.1)
Q22. The implementation of NEMS could reduce the medical staff’s incomes. 3.07 ± 0.97 0.653
Strongly agree 29 (5.5) 13 (7.3) 42 (6.0)
Agree 165 (31.4) 49 (27.4) 214 (30.4)
Neither agree nor disagree 157 (29.9) 57 (31.8) 214 (30.4)
Disagree 159 (30.3) 57 (31.8) 216 (30.7)
Strongly disagree 15 (2.9) 3 (1.7) 18 (2.6)
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fewer than half of the hospital pharmacists considered the
effects of NEMS were satisfactory at present. Identifying
the fundamental causes of the dissatisfaction would need
more researches. Participants did not agree that their in-
come was affected, but this may be because some were re-
luctant to provide accurate information, because this is a
sensitive topic. This might have introduced a slight error.
Previous study [19] reported that the cognition level is
dependent with age, education level, specialty and work
experience. Inconsistently, we found that only education
level and number of training sessions attended were sig-
nificantly related to knowledge scores. Pharmacists in
public secondary/tertiary hospitals performed better
than their counterparts, this can be explained by the fact
that someone with a higher education level, or who re-
ceives more training, is likely to have a better level of
knowledge. Public secondary/tertiary hospitals tended to
have more highly educated professionals and training
opportunities than primary healthcare institutions. The
government could therefore improve pharmacists’ un-
derstanding of NEMS by emphasizing the importance of
talent introduction and training. More attention should
also be paid to primary healthcare institutions where
NEMS has been fully implemented.
Pharmacists reported some problems in the imple-
mentation of NEMS. The most frequently-reported
problem was the supply and distribution system. Similar
results have been found in other developing countries
[36], and this seems to be a global challenge [37–39].
Problems with timely supply and distribution of essential
medicines have serious consequences, such as drug
shortages. As a result, some patients with mild condi-
tions have to attend secondary or tertiary hospitals [40],
which occupies scarce medical resources and increases
patients’ financial burden [32]. Some participants also
thought that government funding was insufficient. In
fact, the government has regularly increased funding
[41], but there may be a cognition gap between the
government and pharmacists. Some participants added
their own comments. Some questioned the principles of
selecting essential medicines. They pointed out that
some cheap drugs with general clinical effects were in-
cluded in the NEML while a number of branded drugs
with good clinical effects and high prices were not,
which needs urgent improvement.
Access to medicine is the key function of NEMS. The
WHO has set out a four-part framework [42] to guide and
coordinate collective action on access to essential medi-
cines. This includes rational selection and use, affordable
prices, sustainable financing and reliable supply systems.
The suggestions included in the questionnaire covered
these four areas. The majority of hospital pharmacists sug-
gested that reliable systems and rational selection and use
were directly related to their work responsibilities. It is
therefore vital to introduce evidence-based selection and
pharmacoeconomics into the development of NEML.
Some participants suggested other solutions, including
raising doctors’ awareness of essential medicines, price
management for essential medicines and standardization
of the distribution system.
Although there have been some studies of hospital
pharmacists, ours is the first to survey a whole province
hospital pharmacists’ knowledge of and attitudes to-
wards the NEMS in China. We took advantage of a
training program targeting hospital pharmacists across
the whole province to conduct the survey. This unique
opportunity to select participants has greatly improved
the representativeness of the survey; meanwhile, the
sampling method may cause a selection bias. This study
also has some other limitations, and its results should be
interpreted with caution. The survey was conducted only
in Shaanxi Province, which may not be typical of the
wider situation in China. Nevertheless, we chose Shaanxi
Province as sample district because it is broadly repre-
sentative of the typical health and health system status
of the 12 western provinces of China [27], and the total
provincial GDP was US$288 billion in 2014, ranking in
the middle level in China. It was conducted in a training
meeting, so a few participants probably completed the
questionnaire in consultation with others. Such behavior
would bias the results somewhat. However, our study
still provides crucial evidence on hospital pharmacists’
knowledge of and attitudes towards the implementation
of NEMS, and the differences between pharmacists in
public secondary/tertiary hospitals and in primary health-
care institutions.
Conclusions
Overall, hospital pharmacists in Shaanxi Province showed
moderate knowledge and attitude levels about the imple-
mentation of NEMS. Compared with those in primary
healthcare institutions, pharmacists in public secondary/
tertiary hospitals performed better, probably because they
were more likely to have a higher level of education and
Table 4 Multiple linear regression analysis showing predictors
of knowledge levels on the NEMS
No. β p-value 95 % CI of β
Model 1
Constant 3.806 <0.001 3.530–4.082
Education level 0.142 0.012 0.031–0.254
Model 2
Constant 3.573 <0.001 3.229–3.917
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receive more training. There is therefore an urgent need
for governments to provide increased opportunities for
further education and training for medical institutions, es-
pecially primary healthcare institutions. Some problems
still exist with the implementation of NEMS, and particu-
larly with the supply and distribution system. Overall, hos-
pital pharmacists deemed reliable systems to be the most
important issue to improve the NEMS.
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